These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 33967609)

  • 1. Relationship between Tertiary Lymphoid Structure and the Prognosis and Clinicopathologic Characteristics in Solid Tumors.
    Zhao Z; Ding H; Lin ZB; Qiu SH; Zhang YR; Guo YG; Chu XD; Sam LI; Pan JH; Pan YL
    Int J Med Sci; 2021; 18(11):2327-2338. PubMed ID: 33967609
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic and clinicopathological significance of tertiary lymphoid structure in non-small cell lung cancer: a systematic review and meta-analysis.
    Ma L; Li R; Liu X; Yu W; Tang Z; Shen Y; Tian H
    BMC Cancer; 2024 Jul; 24(1):815. PubMed ID: 38977962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Presence of Tertiary Lymphoid Structures Provides New Insight Into the Clinicopathological Features and Prognosis of Patients With Breast Cancer.
    Wang B; Liu J; Han Y; Deng Y; Li J; Jiang Y
    Front Immunol; 2022; 13():868155. PubMed ID: 35664009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct Tertiary Lymphoid Structure Associations and Their Prognostic Relevance in HER2 Positive and Negative Breast Cancers.
    Liu X; Tsang JYS; Hlaing T; Hu J; Ni YB; Chan SK; Cheung SY; Tse GM
    Oncologist; 2017 Nov; 22(11):1316-1324. PubMed ID: 28701569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peritumoral tertiary lymphoid structure and tumor stroma percentage predict the prognosis of patients with non-metastatic colorectal cancer.
    Wang Q; Shen X; An R; Bai J; Dong J; Cai H; Zhu H; Zhong W; Chen W; Liu A; Du J
    Front Immunol; 2022; 13():962056. PubMed ID: 36189233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of tertiary lymphoid structures in hepatocellular carcinoma: a meta-analysis and systematic review.
    Hu L; Li X; Yang C; Zhou B; Du C; Jiang N
    Front Immunol; 2024; 15():1390938. PubMed ID: 38887293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Existence of intratumoral tertiary lymphoid structures is associated with immune cells infiltration and predicts better prognosis in early-stage hepatocellular carcinoma.
    Li H; Wang J; Liu H; Lan T; Xu L; Wang G; Yuan K; Wu H
    Aging (Albany NY); 2020 Feb; 12(4):3451-3472. PubMed ID: 32087064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic value of the tertiary lymphoid structure in gastrointestinal cancers.
    Yu A; Cao M; Zhang K; Yang Y; Ma L; Zhang X; Zhao Y; Ma X; Fan Z; Han Z; Wang H
    Front Immunol; 2023; 14():1256355. PubMed ID: 37868990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-infiltrating lymphocyte subsets and tertiary lymphoid structures in pulmonary metastases from colorectal cancer.
    Schweiger T; Berghoff AS; Glogner C; Glueck O; Rajky O; Traxler D; Birner P; Preusser M; Klepetko W; Hoetzenecker K
    Clin Exp Metastasis; 2016 Oct; 33(7):727-39. PubMed ID: 27449756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of tertiary lymphoid structure and tumour infiltrating lymphocytes in oral squamous cell carcinoma.
    Li Q; Liu X; Wang D; Wang Y; Lu H; Wen S; Fang J; Cheng B; Wang Z
    Int J Oral Sci; 2020 Sep; 12(1):24. PubMed ID: 32934197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High endothelial venules proportion in tertiary lymphoid structure is a prognostic marker and correlated with anti-tumor immune microenvironment in colorectal cancer.
    Zhan Z; Shi-Jin L; Yi-Ran Z; Zhi-Long L; Xiao-Xu Z; Hui D; Pan YL; Pan JH
    Ann Med; 2023 Dec; 55(1):114-126. PubMed ID: 36503344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Value of Tumor-Infiltrating Lymphocytes and Tertiary Lymphoid Structures in Epstein-Barr Virus-Associated and -Negative Gastric Carcinoma.
    Cheng N; Li P; Cheng H; Zhao X; Dong M; Zhang Y; Zhao P; Chen J; Shao C
    Front Immunol; 2021; 12():692859. PubMed ID: 34276684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic significance of peritumoral tertiary lymphoid structures in breast cancer.
    Sofopoulos M; Fortis SP; Vaxevanis CK; Sotiriadou NN; Arnogiannaki N; Ardavanis A; Vlachodimitropoulos D; Perez SA; Baxevanis CN
    Cancer Immunol Immunother; 2019 Nov; 68(11):1733-1745. PubMed ID: 31598757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated analysis of tertiary lymphoid structures in relation to tumor-infiltrating lymphocytes and patient survival in pancreatic ductal adenocarcinoma.
    Tanaka T; Masuda A; Inoue J; Hamada T; Ikegawa T; Toyama H; Sofue K; Shiomi H; Sakai A; Kobayashi T; Tanaka S; Nakano R; Yamada Y; Ashina S; Tsujimae M; Yamakawa K; Abe S; Gonda M; Masuda S; Inomata N; Uemura H; Kohashi S; Nagao K; Kanzawa M; Itoh T; Ueda Y; Fukumoto T; Kodama Y
    J Gastroenterol; 2023 Mar; 58(3):277-291. PubMed ID: 36705749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological and prognostic value of tertiary lymphoid structures in lung cancer: a meta-analysis.
    Ma L; Qin X; Yu A; Liu H; Pan D; Gao Y; Wu Z; Chen Z; Han Z
    Clin Transl Oncol; 2024 Aug; ():. PubMed ID: 39212910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of tertiary lymphoid structures (TLS) in digestive system cancers: a systematic review and meta-analysis.
    Sun H; Shi Y; Ran H; Peng J; Li Q; Zheng G; He Y; Liu S; Chang W; Xiao Y
    BMC Cancer; 2023 Dec; 23(1):1248. PubMed ID: 38110876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of tertiary lymphoid structures on clinicopathological, genetic and gene expression characteristics in lung adenocarcinoma.
    Tamiya Y; Nakai T; Suzuki A; Mimaki S; Tsuchihara K; Sato K; Yoh K; Matsumoto S; Zenke Y; Nosaki K; Izumi H; Shibata Y; Sakai T; Taki T; Miyazaki S; Watanabe R; Sakamoto N; Sakashita S; Kojima M; Hashimoto N; Tsuboi M; Goto K; Ishii G
    Lung Cancer; 2022 Dec; 174():125-132. PubMed ID: 36379125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triple-negative breast cancer survival prediction using artificial intelligence through integrated analysis of tertiary lymphoid structures and tumor budding.
    Hou X; Li X; Han Y; Xu H; Xie Y; Zhou T; Xue T; Qian X; Li J; Wang HC; Yan J; Guo X; Liu Y; Liu J
    Cancer; 2024 Apr; 130(S8):1499-1512. PubMed ID: 38422056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrative prognostic analysis of tumor-infiltrating lymphocytes, CD8, CD20, programmed cell death-ligand 1, and tertiary lymphoid structures in patients with early-stage triple-negative breast cancer who did not receive adjuvant chemotherapy.
    Yazaki S; Shimoi T; Yoshida M; Sumiyoshi-Okuma H; Arakaki M; Saito A; Kita S; Yamamoto K; Kojima Y; Nishikawa T; Tanioka M; Sudo K; Noguchi E; Murata T; Shiino S; Takayama S; Suto A; Ohe Y; Fujiwara Y; Yonemori K
    Breast Cancer Res Treat; 2023 Jan; 197(2):287-297. PubMed ID: 36385236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-associated tertiary lymphoid structure predicts postoperative outcomes in patients with primary gastrointestinal stromal tumors.
    Lin Q; Tao P; Wang J; Ma L; Jiang Q; Li J; Zhang G; Liu J; Zhang Y; Hou Y; Lu W; Xue R; Tong H
    Oncoimmunology; 2020; 9(1):1747339. PubMed ID: 32313726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.